Evidence map›Paper›PMID 35697474›Full record

ArticleOpen heart2022

Impact of COVID-19 on patients awaiting ablation for atrial fibrillation.

Charlene Pius, Hasan Ahmad, Richard Snowdon, Reza Ashrafi, Johan Ep Waktare, Zoltan Borbas, Vishal Luther, Saagar Mahida, Simon Modi, Mark Hall and 2 more

Abstract read
In one paragraph

Article in Open heart, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. COVID-19 HEART unveiling as atrial fibrillation: pathophysiology, management and future directions for research.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2023
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Charlene PiusCardiology, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK charlene.pius@lhch.nhs.uk.ORCID 0000-0001-7331-1326
Hasan AhmadCardiology, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK.
Richard SnowdonCardiology, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK.
Reza AshrafiAdult Congenital Heart Disease, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK.
Johan Ep WaktareCardiology, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK.
Zoltan BorbasCardiology, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK.
Vishal LutherCardiology, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK.
Saagar MahidaCardiology, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK.
Simon ModiCardiology, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK.ORCID 0000-0003-3520-6124
Mark HallCardiology, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK.
Dhiraj GuptaCardiology, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK.ORCID 0000-0002-3490-090X
Derick ToddCardiology, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAtrial fibrillation (AF) ablation services were significantly affected by the COVID-19 pandemic. We aimed to evaluate a symptom-based clinician prioritisation scheme for waiting list management compared with patient-completed quality of life (QoL) scores. We also sought to understand factors influencing QoL, particularly the impact of COVID-19, on patients awaiting AF ablation, via a bespoke questionnaire.

methodsPatients awaiting AF ablation were sent two QoL questionnaires (Atrial Fibrillation Effect on QualiTy of Life (AFEQT) and EuroQol 5D (EQ5D-5L)) and the bespoke questionnaire. At a separate time point, patients were categorised as C1-urgent, C2-priority or C3-routine by their cardiologist based on review of clinic letters.

resultsThere were 118 patients included with priority categorisation available for 86 patients. Median AFEQT scores were lower in C2 (30.4; 17.2-51.9) vs C3 patients (56.5; 32.1-74.1; p<0.01). Unplanned admission occurred in 3 patients in C3 with AFEQT scores of <40. Although 65 patients had AF symptoms during the pandemic, 43.1% did not seek help where they ordinarily would have. An exercise frequency of ≥3-4 times a week was associated with higher AFEQT (56.5; 41.2-74.1; p<0.001) and EQ5D (0.84; 0.74-0.88; p<0.0001) scores.

conclusionThe QoL of patients awaiting AF ablation is impaired and AFEQT helps to identify patients at risk of admission, over and above physician assessment. COVID-19 influenced patients seeking medical attention with symptomatic AF when they normally would. Regular exercise is associated with better QoL in patients awaiting AF ablation.

Indexed as

Atrial FibrillationCatheter AblationCOVID-19HumansPandemicsQuality of Lifeatrial fibrillationcatheter ablationCOVID-19delivery of health care

Identifiers

PMID35697474
PMCPMC9195158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.